STEPS TAKEN AFTER GRANTING THE MARKETING AUTHORISATION 
For procedure finalised after 1 January 2005 please refer to module 8B 
Scope 
Application 
number 
Type of 
modification1 
Notification/ 
Opinion 
issued on2 
Transfer of Marketing Authorisation Holder 
Change in the manufacturing authorisation 
Change in the name of a manufacturer of the active substance 
Transfer of Marketing Authorisation Holder 
Change in the manufacturing authrisation 
Change in the name of the manufacturer of active substance 
1st annual reassessment of benefit/risk profile 
Extension of retest period of active substance 
Extension of shelf-life of finished product 
2nd annual reassessment of benefit/risk profile 
T/001 
I/002 
I/003 
T/004 
I/005 
I/006 
S/007 
I/008 
I/009 
S/010 
T 
I 
I 
T 
I 
I 
S 
I 
I 
S 
11.12.01 
25.01.02 
17.01.02 
06.08.02 
11.11.02 
06.11.02 
19.03.03 
15.08.03 
09.09.03 
20.11.03 
Commission 
Decision 
Issued/amen
ded on 
19.02.02 
12.04.02 
06.03.02 
13.09.02 
05.12.02 
12.11.02 
09.07.03 
20.08.03 
20.10.03 
20.02.04 
1 In accordance with Commission Regulation (EC) No. 542/95 of 10 March 1995, as amended: I refers to a 
minor variation (Type I variation); II refers to a major variation (Type II variation); I/II refers to a minor 
variation following the procedure set out in Article 6, 7 and 8 of the Regulation; X refers to an Annex II 
application. 
T refers to a transfer of a Marketing Authorisation in accordance with Commission Regulation (EC) No 2141/96 
of 7 November 1996.  
N refers to a notification in accordance with Article 10(3) of Council Directive 92/27/EEC of 31 March 1992. 
2 For Notifications and Type I variations, the date of entry into force of the change is the EMEA Notification 
date. The Commission Decision will be amended accordingly. 
1/1  
ï£© EMEA 2005 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                                                            
 
